What’s The Future For Medco’s Personalized Medicine Program?
Express Scripts considers Medco’s personalized medicine program to be complementary to its own expertise in consumer behavior and care coordination, according to presentations on the proposed merger between the two pharmacy benefit managers. But it’s not clear how committed to the program Express Scripts will be.
You may also be interested in...
Express Scripts-Medco Deal Fits Post-Health Reform Realities, But Was Hastened By Contract Losses
Express Scripts’ merger agreement with Medco to form a mega-pharmacy benefits manager may fit into the new realities of the post-health care reform world, but it was also likely hastened by contract losses at Medco.
Keytruda, Opdivo May Be Only Part B Drugs Chosen For Medicare Negotiation In First Applicable Year
In general, more Part D drugs will be eligible than Part B drugs in the early years of the program because Part D drugs have higher levels of spending and so will dominate the list of candidates. A new report sizes up the drugs that would qualify for Medicare Price negotiation in 2026-2028.